Diabetes & Endocrinology
Medicines
Euro Biom supplies a comprehensive range of diabetes and endocrinology medicines to hospitals, clinics, NGO health programmes and international distributors. Our portfolio includes GLP-1 receptor agonists (including semaglutide), SGLT2 inhibitors, DPP-4 inhibitors, oral antidiabetics, thyroid medicines and hormonal therapies.
Search Our Diabetes & Endocrinology Range
All products sourced from UK and EU licensed manufacturers. Contact us to enquire about any product.
Showing all 337 products
No products found. Contact us, we can likely source it.
Diabetes & Endocrinology Medicine Supply: Semaglutide & Beyond
Diabetes is one of the fastest-growing non-communicable diseases globally, with the GCC and African regions experiencing particularly rapid increases in prevalence. Euro Biom has established supply routes for diabetes medicines into these markets, including for products on shortage, unregistered locally, or required in large quantities for institutional health programmes.
GLP-1 receptor agonists including semaglutide (Ozempic/Rybelsus), liraglutide (Victoza), and dulaglutide (Trulicity) have experienced sustained global demand and periodic shortage, Euro Biom can source these via your country's named-patient import route where standard supply is constrained. Our SGLT2 inhibitor range covers empagliflozin, dapagliflozin, and canagliflozin. DPP-4 inhibitors include sitagliptin, linagliptin, saxagliptin and alogliptin.
Endocrinology medicines include levothyroxine (all strengths), carbimazole, propylthiouracil, hydrocortisone (including paediatric formulations such as Alkindi), fludrocortisone, somatropin (growth hormone), and octreotide/lanreotide for acromegaly and carcinoid syndrome.
Sourcing Semaglutide or GLP-1 Agonists?
We supply diabetes medicines to hospitals, NGOs and international distributors, including GLP-1 agonists on shortage. Contact us for availability and pricing.
Submit an Enquiry →